Literature DB >> 20558736

Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.

Giuseppe D'Argenio1, Orsolina Petillo, Sabrina Margarucci, Angela Torpedine, Anna Calarco, Angela Koverech, Angelo Boccia, Giovanni Paolella, Gianfranco Peluso.   

Abstract

In the large intestine organic cation transporter type-2 (OCTN2) is recognized as a transporter of compounds such as carnitine and colony sporulation factor, promoting health of the colon intestinal epithelium. Recent reports suggest that OCTN2 expression in small intestine is under control of peroxisome proliferator-activated receptor-alpha (PPARalpha). However, PPARalpha contribution to colonic OCTN2 expression remains controversial. Here we examined the transcriptional regulation of colon OCTN2 gene by PPARgamma. To exclude any additional modulation of other PPAR to OCTN2 expression, we used both in vivo and in vitro PPAR-null models and specific PPAR inhibitors. The PPARgamma agonists thiazolidinediones increased both OCTN2 mRNA and protein expression in colonic epithelial cell lines independently by PPARalpha expression. The induction was blocked only by PPARgamma antagonists or by gammaORF4, a PPARgamma isoform with dominant negative activity, suggesting a PPARgamma-dependent mechanism. A conserved noncanonical PPAR-responsive element was found by computational analysis in the first intron of human OCTN2 gene and validated by EMSA assay. Promoter-reporter assays further confirmed transcriptional functionality of the putative PPAR response element, whereas selective mutation caused complete loss of responsiveness to PPARgamma activation. Finally, adenovirus-mediated overexpression of constitutively active PPARgamma mutant increased colon OCTN2 expression in PPARalpha(-/-) mice. Interestingly, animals overexpressing colon PPARgamma showed a significant increase in plasma carnitine, thus demonstrating the functional contribution of large intestine to systemic carnitine homeostasis. This study reveals a PPARgamma-dependent absorption machinery in colon that is likely involved in the health of colon epithelium, in the microbiota-host interactions and in the absorption of nutraceuticals and drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558736      PMCID: PMC2930707          DOI: 10.1074/jbc.M110.109678

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Regional distribution of solute carrier mRNA expression along the human intestinal tract.

Authors:  Yvonne Meier; Jyrki J Eloranta; Jutta Darimont; Manfred G Ismair; Christian Hiller; Michael Fried; Gerd A Kullak-Ublick; Stephan R Vavricka
Journal:  Drug Metab Dispos       Date:  2007-01-12       Impact factor: 3.922

2.  The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter.

Authors:  Mikihiro Fujiya; Mark W Musch; Yasushi Nakagawa; Shien Hu; John Alverdy; Yutaka Kohgo; Olaf Schneewind; Bana Jabri; Eugene B Chang
Journal:  Cell Host Microbe       Date:  2007-06-14       Impact factor: 21.023

Review 3.  Carnitine metabolism and its regulation in microorganisms and mammals.

Authors:  C J Rebouche; H Seim
Journal:  Annu Rev Nutr       Date:  1998       Impact factor: 11.848

4.  Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors.

Authors:  S Mandard; R Stienstra; P Escher; N S Tan; I Kim; F J Gonzalez; W Wahli; B Desvergne; M Müller; S Kersten
Journal:  Cell Mol Life Sci       Date:  2007-05       Impact factor: 9.261

5.  Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.

Authors:  I Tamai; R Ohashi; J Nezu; H Yabuuchi; A Oku; M Shimane; Y Sai; A Tsuji
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

6.  Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats.

Authors:  Robert Ringseis; Stefanie Pösel; Frank Hirche; Klaus Eder
Journal:  Pharmacol Res       Date:  2007-06-16       Impact factor: 7.658

7.  L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.

Authors:  C Ciacci; G Peluso; E Iannoni; M Siniscalchi; P Iovino; A Rispo; R Tortora; C Bucci; F Zingone; S Margarucci; M Calvani
Journal:  Dig Liver Dis       Date:  2007-08-10       Impact factor: 4.088

8.  Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.

Authors:  J Nezu; I Tamai; A Oku; R Ohashi; H Yabuuchi; N Hashimoto; H Nikaido; Y Sai; A Koizumi; Y Shoji; G Takada; T Matsuishi; M Yoshino; H Kato; T Ohura; G Tsujimoto; J Hayakawa; M Shimane; A Tsuji
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

9.  Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes.

Authors:  Giuseppe D'Argenio; Menotti Calvani; Amelia Casamassimi; Orsolina Petillo; Sabrina Margarucci; Monica Rienzo; Ivana Peluso; Riccardo Calvani; Alfredo Ciccodicola; Nicola Caporaso; Gianfranco Peluso
Journal:  FASEB J       Date:  2006-10-25       Impact factor: 5.191

Review 10.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

View more
  9 in total

Review 1.  The Impact of Carnitine on Dietary Fiber and Gut Bacteria Metabolism and Their Mutual Interaction in Monogastrics.

Authors:  Abdallah Ghonimy; Dong Ming Zhang; Mohammed Hamdy Farouk; Qiuju Wang
Journal:  Int J Mol Sci       Date:  2018-03-28       Impact factor: 5.923

2.  Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.

Authors:  Shiwei Zhou; Yan Shu
Journal:  Drug Metab Dispos       Date:  2022-05-29       Impact factor: 3.579

3.  Population pharmacokinetic study of memantine: effects of clinical and genetic factors.

Authors:  Muriel Noetzli; Monia Guidi; Karsten Ebbing; Stephan Eyer; Laurence Wilhelm; Agnès Michon; Valérie Thomazic; Abdel-Messieh Alnawaqil; Sophie Maurer; Serge Zumbach; Panteleimon Giannakopoulos; Armin von Gunten; Chantal Csajka; Chin B Eap
Journal:  Clin Pharmacokinet       Date:  2013-03       Impact factor: 6.447

4.  PPAR-γ regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flow.

Authors:  Shruti Sharma; Xutong Sun; Ruslan Rafikov; Sanjiv Kumar; Yali Hou; Peter E Oishi; Sanjeev A Datar; Gary Raff; Jeffrey R Fineman; Stephen M Black
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

5.  Regulation of Genes Involved in Carnitine Homeostasis by PPARα across Different Species (Rat, Mouse, Pig, Cattle, Chicken, and Human).

Authors:  Robert Ringseis; Gaiping Wen; Klaus Eder
Journal:  PPAR Res       Date:  2012-10-23       Impact factor: 4.964

6.  Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines.

Authors:  Qiang Qu; Jian Qu; Min Zhan; Lan-Xiang Wu; Yi-Wen Zhang; Xiao-Ya Lou; Li-Juan Fu; Hong-Hao Zhou
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

7.  Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα Pathway.

Authors:  Jian Luo; Jian Qu; Rui Yang; Meng-Xue Ge; Yin Mei; Bo-Ting Zhou; Qiang Qu
Journal:  Front Pharmacol       Date:  2016-06-29       Impact factor: 5.810

Review 8.  The Link Between the Mitochondrial Fatty Acid Oxidation Derangement and Kidney Injury.

Authors:  Lara Console; Mariafrancesca Scalise; Nicola Giangregorio; Annamaria Tonazzi; Maria Barile; Cesare Indiveri
Journal:  Front Physiol       Date:  2020-07-09       Impact factor: 4.566

Review 9.  SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.

Authors:  Barbara Juraszek; Katarzyna A Nałęcz
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.